IMARC Research Focuses On Strategic Growth in 2020

  • 7

STRONGSVILLE, Ohio, May 21, 2019 (GLOBE NEWSWIRE) -- IMARC Research is expanding its reach as a full-service, global contract research organization through several key promotions, new partnerships and additional services.

Brandy Chittester will assume operational responsibilities as IMARC’s new President, while IMARC founder Sandra Maddock will focus on strategic growth as the company’s CEO. Ms. Chittester has worked with IMARC for 12 years and currently serves as the Chief of Clinical Operations, managing IMARC’s clinical team and assisting with high-level consulting projects.

Ms. Maddock started IMARC as an individual consultant and has grown the company to a team of over 60 experienced professionals working with some of the largest medical device companies in the world. IMARC has supported an extensive portfolio of clinical research projects in its 20-year history while maintaining a stellar record with the FDA. Not a single FDA warning letter has been issued to any of its sites or clients.

As the regulatory landscape has evolved, Maddock will focus on developing new global partnerships to meet the growing needs of medical device manufacturers. That includes expanding IMARC’s presence in the European Union to meet new MDR and IVDR regulations, which take effect in May 2020 and May 2022, respectively.

IMARC is also naming James Moat as Director, Project Management Services. Mr. Moat has worked with IMARC for three years and currently services as the Director of Minneapolis Operations while also providing high-level consulting and Project Management services to IMARC’s clients. Additionally, at the same time the EU and the US introduce further regulation for medical devices to require more real-world evidence, IMARC has also added clinical research data management to its comprehensive services.

“As IMARC works with a growing number of global clients, providing full-service support, including data management has become a crucial part of the clinical trial lifecycle,” Maddock said. “Our team assists sponsors with data management at every stage, from choosing the right electronic data capture platform to data entry, validation and statistical analysis so they can respond to inquiries with confidence and earn approval faster.”

To learn more about IMARC’s comprehensive clinical research services, visit our newly updated website, imarcresearch.com.

Contact:

John Lehmann, Business Development Manager

[email protected]

440-801-1540

ti?nf=NzYyNDI2OCMyOTQ2NjIzIzUwMDA0NTMzNg==

imarc-FINAL.jpg

GlobeNewsWire
GlobeNewsWire

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases, financial disclosures and multimedia content to media, investors, and consumers worldwide.